Holiday Notice: Expect delayed shipping. Orders ship 4/6.
FOR RESEARCH PURPOSES ONLY. NOT FOR HUMAN CONSUMPTION.

Oxytocin — Published Research

Reviewed by: Dr. James Porter, PhD| Last updated: February 24, 2026|For laboratory reference only

← Back to Oxytocin product page

Research Library

Published research on oxytocin — for educational purposes only

Oxytocin Receptor Signaling and G Protein Coupling

The oxytocin receptor (OXTR) is a class A G protein-coupled receptor that primarily couples to Gαq/11, activating phospholipase C-β and triggering IP₃-mediated calcium release from endoplasmic reticulum stores. OXTR also couples to Gαi in some cellular contexts, inhibiting adenylyl cyclase. Receptor binding studies demonstrate high affinity for oxytocin (Ki ~1 nM) with lower affinity for the structurally related vasopressin peptide. OXTR expression varies across tissues and is regulated by estrogen and other factors.

Gimpl G, Fahrenholz F. “The Oxytocin Receptor System: Structure, Function, and Regulation.” Physiol Rev. 2001. PubMed

Oxytocin Receptor Pharmacology and Drug Design

Research on OXTR pharmacology has focused on developing selective agonists and antagonists for receptor characterization. Structure-activity relationship studies have identified critical residues for receptor binding, including the Tyr² and Ile³ positions as key determinants of OXTR versus vasopressin receptor selectivity. Cyclic and linear peptide analogs have been synthesized and characterized for potency, selectivity, and metabolic stability. Non-peptide OXTR ligands have also been developed as pharmacological tools for receptor studies.

Manning M et al. “Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics.” J Neuroendocrinol. 2012. PubMed

Central Oxytocin Signaling Research

Oxytocin neurons in the paraventricular nucleus (PVN) and supraoptic nucleus (SON) project to numerous brain regions including the amygdala, hippocampus, and nucleus accumbens. Central OXTR activation has been studied in relation to social behavior, stress responses, and reward circuitry using optogenetic, chemogenetic, and pharmacological approaches. Animal model studies have characterized oxytocin’s role in modulating neural circuits involved in social cognition and anxiety-related behaviors through electrophysiological and behavioral assays.

Meyer-Lindenberg A et al. “Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine.” Nat Rev Neurosci. 2011. PubMed

Disclaimer: All research citations are provided for educational purposes only. These references describe findings from in vitro and animal model studies. This information does not constitute medical advice and should not be interpreted as endorsement of any specific application.

Reviewed by

Dr. James Porter, PhD

Biochemist with a focus on peptide synthesis and structure-activity relationships. Reviews research summaries for scientific accuracy.

Editorial Review

Reviewed by Dr. Sarah Chen, PharmD and Dr. James Porter, PhD — Panda Peptides Research Team.

Last reviewed: April 2026.

This content summarizes published peer-reviewed research for educational purposes only. It is not medical advice and does not constitute a recommendation for any specific compound or protocol.